Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.

PURPOSE OF REVIEW: Some of the 20% of myasthenia gravis patients who do not have antibodies to acetylcholine receptors (AChRs) have antibodies to muscle specific kinase (MuSK), but a full understanding of their frequency, the associated clinical phenotype and the mechanisms of action of the antibod...

Cijeli opis

Bibliografski detalji
Glavni autori: Vincent, A, Leite, M
Format: Journal article
Jezik:English
Izdano: 2005